Novartis Investigative Site

Jenin, Buenos Aires 6000

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Events, Multiple Sclerosis

Studies at this site

• Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies — Completed
• A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People — Stopped early